AIC
RPRX icon

Ameritas Investment Company’s Royalty Pharma RPRX Stock Holding History

Ameritas Investment Company’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,831
Closed -$239K – 762
2021
Q2 		$239K Buy
5,831
+152
+3% +$6.46K 0.01% 643
2021
Q1 		$248K Buy
5,679
+386
+7% +$18.3K 0.02% 515
2020
Q4 		$265K Buy
+5,293
New +$225K 0.05% 337

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Company's RPRX Position: Q3 2021 in Review

Ameritas Investment Company sold out of Royalty Pharma (RPRX) in Q3 2021, closing a stake of 5,831 shares — an estimated $239K sold.

Ameritas Investment Company first reported a position in RPRX in Q4 2020 and held it in 3 quarters. The position peaked at $265K in Q4 2020. 232 funds tracked by Wall St. Rank hold RPRX as of Q3 2021.

  • Ameritas Investment Company reported no remaining Royalty Pharma position as of Q3 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 5,831 Royalty Pharma shares in Q3 2021, an estimated $239K.
  • Ameritas Investment Company first reported a position in Royalty Pharma in Q4 2020 and held it in 3 quarters.
  • Ameritas Investment Company's Royalty Pharma position peaked at $265K in Q4 2020.
  • 232 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.